Global Assets Advisory LLC Sells 1,689 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Global Assets Advisory LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 59.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,140 shares of the healthcare conglomerate’s stock after selling 1,689 shares during the quarter. Global Assets Advisory LLC’s holdings in UnitedHealth Group were worth $575,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Norges Bank purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at about $6,375,744,000. Raymond James Financial Inc. bought a new stake in UnitedHealth Group in the 4th quarter worth approximately $1,914,740,000. Amundi boosted its position in shares of UnitedHealth Group by 97.2% during the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock valued at $3,183,132,000 after acquiring an additional 2,991,470 shares during the last quarter. Proficio Capital Partners LLC increased its position in UnitedHealth Group by 76,830.4% in the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock worth $955,388,000 after purchasing an additional 1,886,186 shares during the last quarter. Finally, Northern Trust Corp grew its stake in shares of UnitedHealth Group by 12.5% in the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock worth $4,807,527,000 after buying an additional 1,058,488 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on UNH shares. Royal Bank of Canada dropped their price target on UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. JPMorgan Chase & Co. cut their target price on UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating on the stock in a research report on Thursday, April 24th. Robert W. Baird dropped their price objective on shares of UnitedHealth Group from $640.00 to $510.00 and set an “outperform” rating for the company in a research note on Tuesday, April 29th. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Barclays reduced their price objective on shares of UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating on the stock in a research report on Monday, April 21st. Four equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $596.86.

UnitedHealth Group Trading Down 1.3 %

NYSE:UNH opened at $380.72 on Friday. The firm has a market cap of $346.54 billion, a P/E ratio of 24.56, a P/E/G ratio of 1.37 and a beta of 0.56. The firm has a 50-day simple moving average of $488.01 and a 200-day simple moving average of $522.60. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a one year low of $378.54 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter in the prior year, the business posted $6.91 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.21%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.18%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.